Antiviral activity of human lactoferrin: inhibition of alphavirus interaction with heparan sulfate. (Q40456516)

20 September 2017

Antiviral activity of human lactoferrin: inhibition of alphavirus interaction with heparan sulfate. (English)

1 reference

20 September 2017

7

Jan Wilschut

1 reference

20 September 2017

Barry-Lee Waarts

1

1 reference

20 September 2017

Onwuchekwa J C Aneke

2

1 reference

20 September 2017

Jolanda M Smit

3

1 reference

20 September 2017

Koji Kimata

4

1 reference

20 September 2017

Robert Bittman

5

1 reference

20 September 2017

Dirk K F Meijer

6

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

20 September 2017

9

1 reference

inferred from page(s)

published in

Virology

1 reference

20 September 2017

333

1 reference

20 September 2017

2

1 reference

20 September 2017

284-292

1 reference

Antiadenovirus activity of milk proteins: lactoferrin prevents viral infection

20 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

Inhibition of cytomegalovirus infection by lactoferrin in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

Mutations in the E2 glycoprotein of Venezuelan equine encephalitis virus confer heparan sulfate interaction, low morbidity, and rapid clearance from blood of mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

Functions of cell surface heparan sulfate proteoglycans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

Cell surface heparan sulfate is a receptor for human herpesvirus 8 and interacts with envelope glycoprotein K8.1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

A rapid and sensitive sub-micro phosphorus determination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

A single nucleotide change in the E2 glycoprotein gene of Sindbis virus affects penetration rate in cell culture and virulence in neonatal mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

Heparin-interacting sites of bovine lactoferrin are involved in anti-adenovirus activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

Echoviruses bind heparan sulfate at the cell surface.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

The role of breastfeeding in prevention of neonatal infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

Inhibition with lactoferrin of in vitro infection with human herpes virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

An Amino Acid Substitution in the Coding Region of the E2 Glycoprotein Adapts Ross River Virus To Utilize Heparan Sulfate as an Attachment Moiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

On the entry of Semliki forest virus into BHK-21 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

Lactoferrin and its biological functions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

A new generation of animal cell expression vectors based on the Semliki Forest virus replicon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

Lactoferrin inhibits enterovirus 71 infection of human embryonal rhabdomyosarcoma cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

Lactoferrin inhibits herpes simplex virus type 1 adsorption to Vero cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

Inhibition of poliovirus type 1 infection by iron-, manganese- and zinc-saturated lactoferrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

Monensin inhibits Semliki Forest virus penetration into culture cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

Penetration of Semliki Forest virus from acidic prelysosomal vacuoles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

In vitro antiviral activity of lactoferrin and ribavirin upon hantavirus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

A simplification of the protein assay method of Lowry et al. which is more generally applicable

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

Antiviral effect of bovine lactoferrin saturated with metal ions on early steps of human immunodeficiency virus type 1 infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

PE2 cleavage mutants of Sindbis virus: correlation between viral infectivity and pH-dependent membrane fusion activation of the spike heterodimer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

Adaptation of alphaviruses to heparan sulfate: interaction of Sindbis and Semliki forest viruses with liposomes containing lipid-conjugated heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

Liposomes as Target Membranes in the Study of Virus Receptor Interaction and Membrane Fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

Glycosaminoglycan-binding ability is a feature of wild-type strains of herpes simplex virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

7 January 2021

Antiviral activities of lactoferrin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

Characterization of the glycosaminoglycan-binding region of lactoferrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

The binding of lactoferrin to glycosaminoglycans on enterocyte-like HT29-18-C1 cells is mediated through basic residues located in the N-terminus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

Binding of Sindbis virus to cell surface heparan sulfate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

7 January 2021

In vitro mutagenesis of a full-length cDNA clone of Semliki Forest virus: the small 6,000-molecular-weight membrane protein modulates virus release

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

7 January 2021

Sindbis virus mutations which coordinately affect glycoprotein processing, penetration, and virulence in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

7 January 2021

Low-pH-dependent fusion of Sindbis virus with receptor-free cholesterol- and sphingolipid-containing liposomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

7 January 2021

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.01.010

7 January 2021

10.1016/J.VIROL.2005.01.010

Identifiers

DOI

1 reference

20 September 2017

1 reference